Sana Biotechnology Inc (SANA)

$3.29 +0.01 (0.30%)
Market Cap 912.80M
Revenue (ttm) 0.00
Net Income (ttm) -244.17M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 3,652,900
Avg Vol 3,526,548
Day's Range N/A - N/A
Shares Out 278.29M
Stochastic %K 50%
Beta 2.13
Analysts Strong Sell
Price Target $9.50

Company Profile

Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines in the United States. It develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including type 1 diabetes, B cell mediated autoimmune diseases, and oncology. The company's product pipeline includes UP421, a HIP-modified allogeneic primary islet cell product, which is in phase 1 clinical trial to treat type 1 diabetes; SC451, a HIP-modifi...

Industry: Biotechnology
Sector: Healthcare
Phone: 206 701 7914
Address:
188 East Blaine Street, Suite 400, Seattle, United States
cryptobot1234
cryptobot1234 Jul. 29 at 4:10 PM
$SANA what is going on??
0 · Reply
LoveRetailFroth
LoveRetailFroth Jul. 29 at 12:33 PM
$AMLX Good Morning ☕️ $RXRX $SANA $TEM
0 · Reply
BBraggHillBoys
BBraggHillBoys Jul. 28 at 7:14 PM
$SANA hold that $3.36 reclaim; keep that volume pumping
0 · Reply
LoveRetailFroth
LoveRetailFroth Jul. 28 at 6:50 PM
$SANA Let’s go🚀
0 · Reply
BBraggHillBoys
BBraggHillBoys Jul. 28 at 3:52 PM
$SANA a move through $3.36 with noticably accelerating volume would be a meaningful confirmation.
0 · Reply
LoveRetailFroth
LoveRetailFroth Jul. 28 at 2:23 PM
$AMLX Good Morning ☕️ My Bio 💎 s $RXRX $SANA $TEM
0 · Reply
Y007
Y007 Jul. 28 at 2:21 PM
$SANA
0 · Reply
bubbaxyz
bubbaxyz Jul. 27 at 11:25 PM
$SANA when when when🫡
0 · Reply
Harold2029
Harold2029 Jul. 27 at 6:35 PM
$SANA this will: fly, halt, fly, halt and fly some more! … mark this post!
0 · Reply
BBraggHillBoys
BBraggHillBoys Jul. 27 at 2:33 PM
$SANA in the first hour , volume increased substantially without the price giving back much of the move.
0 · Reply
Latest News on SANA
Did Sana Biotechnology, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Jul 29, 2026, 10:09 AM EDT - 2 hours ago

Did Sana Biotechnology, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Sana Biotechnology announces publication of long-term diabetes data

2026-07-13T13:30:18.000Z - 16 days ago

Sana Biotechnology announces publication of long-term diabetes data

Sana Biotechnology Announces Follow-On Publication in The New England Journal of Medicine (NEJM) Highlighting Groundbreaking Long-Term Data and Durability of Hypoimmune-Modified Islet Cell Transplantation Without Immunosuppression in Type 1 Diabetes

Jul 13, 2026, 8:00 AM EDT - 16 days ago

Sana Biotechnology Announces Follow-On Publication in The New England Journal of Medicine (NEJM) Highlighting Groundbreaking Long-Term Data and Durability of Hypoimmune-Modified Islet Cell Transplantation Without Immunosuppression in Type 1 Diabetes

Sana Biotechnology Announces Symposium Presentation at the European Association for the Study of Diabetes (EASD) Annual Meeting 2026

Jul 1, 2026, 9:00 AM EDT - 4 weeks ago

Sana Biotechnology Announces Symposium Presentation at the European Association for the Study of Diabetes (EASD) Annual Meeting 2026

Sana Biotechnology Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jun 9, 2026, 4:00 PM EDT - 7 weeks ago

Sana Biotechnology Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Sana Biotechnology Transcript: Jefferies Global Healthcare Conference 2026

Jun 3, 2026, 9:20 AM EDT - 2 months ago

Sana Biotechnology Transcript: Jefferies Global Healthcare Conference 2026

Did Sana Biotechnology, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Jun 2, 2026, 6:11 PM EDT - 2 months ago

Did Sana Biotechnology, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Sana Biotechnology to Present at June 2026 Investor Conferences

May 27, 2026, 4:05 PM EDT - 2 months ago

Sana Biotechnology to Present at June 2026 Investor Conferences

Sana Biotechnology Announces Sale of Approximately $69 Million of Shares Through its At-the-Market (ATM) Facility

May 15, 2026, 9:00 AM EDT - 2 months ago

Sana Biotechnology Announces Sale of Approximately $69 Million of Shares Through its At-the-Market (ATM) Facility

Sana Biotechnology presents preclinical data for in vivo CAR T cell therapy

2026-05-12T22:28:22.000Z - 2 months ago

Sana Biotechnology presents preclinical data for in vivo CAR T cell therapy

Sana Biotechnology Transcript: Bank of America Global Healthcare Conference 2026

May 12, 2026, 5:20 PM EDT - 2 months ago

Sana Biotechnology Transcript: Bank of America Global Healthcare Conference 2026

Sana Biotechnology Presents Preclinical Data for In Vivo CAR T Cell Therapy SG293 Surrogate Demonstrating Cell-Specific Delivery, Potent CAR T Cell Generation, and Deep B Cell Depletion in NHPs

May 12, 2026, 4:05 PM EDT - 2 months ago

Sana Biotechnology Presents Preclinical Data for In Vivo CAR T Cell Therapy SG293 Surrogate Demonstrating Cell-Specific Delivery, Potent CAR T Cell Generation, and Deep B Cell Depletion in NHPs

Sana Biotechnology reports Q1 non-GAAP EPS (14c), consensus (15c)

2026-05-11T20:42:28.000Z - 2 months ago

Sana Biotechnology reports Q1 non-GAAP EPS (14c), consensus (15c)

Sana Biotechnology Reports First Quarter 2026 Financial Results and Business Updates

May 11, 2026, 4:05 PM EDT - 2 months ago

Sana Biotechnology Reports First Quarter 2026 Financial Results and Business Updates

Sana Biotechnology Earnings release: Q1 2026

May 11, 2026, 4:00 PM EDT - 2 months ago

Sana Biotechnology Earnings release: Q1 2026

Sana Biotechnology Quarterly report: Q1 2026

May 11, 2026, 4:00 PM EDT - 2 months ago

Sana Biotechnology Quarterly report: Q1 2026

Sana Biotechnology Slides: Corporate presentation

May 11, 2026, 4:00 PM EDT - 2 months ago

Sana Biotechnology Slides: Corporate presentation

Sana Biotechnology initiated with a Buy at Rodman & Renshaw

2026-05-11T17:02:47.000Z - 2 months ago

Sana Biotechnology initiated with a Buy at Rodman & Renshaw

Sana Biotechnology to Present at the BofA Securities 2026 Healthcare Conference

May 5, 2026, 4:05 PM EDT - 3 months ago

Sana Biotechnology to Present at the BofA Securities 2026 Healthcare Conference

Sana Biotechnology Announces Oral Presentation Highlighting Preclinical Data from in vivo CAR T SG293 at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting

Apr 27, 2026, 4:30 PM EDT - 3 months ago

Sana Biotechnology Announces Oral Presentation Highlighting Preclinical Data from in vivo CAR T SG293 at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting

Sana Biotechnology Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 3 months ago

Sana Biotechnology Proxy statement: Proxy filing

Sana Biotechnology Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 3 months ago

Sana Biotechnology Proxy statement: Proxy filing

Sana Biotechnology price target raised to $7 from $6 at Wedbush

2026-04-14T13:23:10.000Z - 3 months ago

Sana Biotechnology price target raised to $7 from $6 at Wedbush

Sana Biotechnology announces SC451 strategic collaboration with Mayo Clinic

2026-04-13T20:18:08.000Z - 3 months ago

Sana Biotechnology announces SC451 strategic collaboration with Mayo Clinic

Sana Biotechnology Slides: Corporate presentation

Apr 13, 2026, 7:00 AM EDT - 3 months ago

Sana Biotechnology Slides: Corporate presentation

Sana announces follow-up results from first-in-human study transplanting UP421

2026-03-13T13:10:51.000Z - 4 months ago

Sana announces follow-up results from first-in-human study transplanting UP421

Sana Biotechnology Transcript: The Citizens Life Sciences Conference 2026

Mar 11, 2026, 1:40 PM EDT - 4 months ago

Sana Biotechnology Transcript: The Citizens Life Sciences Conference 2026

Sana Biotechnology files automatic mixed securities shelf

2026-03-03T22:25:38.000Z - 5 months ago

Sana Biotechnology files automatic mixed securities shelf

Sana Biotechnology reports Q4 EPS (16c), consensus (13c)

2026-03-03T21:25:24.000Z - 5 months ago

Sana Biotechnology reports Q4 EPS (16c), consensus (13c)

Sana Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates

Mar 3, 2026, 4:05 PM EST - 5 months ago

Sana Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates

Sana Biotechnology Annual report: Q4 2025

Mar 3, 2026, 3:00 PM EST - 5 months ago

Sana Biotechnology Annual report: Q4 2025

Sana Biotechnology Earnings release: Q4 2025

Mar 3, 2026, 3:00 PM EST - 5 months ago

Sana Biotechnology Earnings release: Q4 2025

Sana Biotechnology Transcript: TD Cowen 46th Annual Health Care Conference

Mar 2, 2026, 1:10 PM EST - 5 months ago

Sana Biotechnology Transcript: TD Cowen 46th Annual Health Care Conference

Sana Biotechnology to Present at March 2026 Investor Conferences

Feb 23, 2026, 4:05 PM EST - 5 months ago

Sana Biotechnology to Present at March 2026 Investor Conferences

Sana Biotechnology appoints Piper as EVP, CFO

2026-02-17T14:16:15.000Z - 5 months ago

Sana Biotechnology appoints Piper as EVP, CFO

Sana Biotechnology Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 12:45 PM EST - 6 months ago

Sana Biotechnology Transcript: 44th Annual J.P. Morgan Healthcare Conference

Sana Biotechnology Slides: Corporate presentation

Jan 14, 2026, 12:00 PM EST - 6 months ago

Sana Biotechnology Slides: Corporate presentation

Sana Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference

Jan 7, 2026, 4:26 PM EST - 7 months ago

Sana Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference

Sana Biotechnology price target raised to $7 from $6 at BofA

2026-01-06T15:25:24.000Z - 7 months ago

Sana Biotechnology price target raised to $7 from $6 at BofA

Sana Biotechnology announces publication of in vivo gene editing

2025-12-08T14:05:59.000Z - 8 months ago

Sana Biotechnology announces publication of in vivo gene editing

Sana Biotechnology Announces Publication in Nature Biotechnology of in vivo Gene Editing of Human Hematopoietic Stem Cells in Preclinical Models Using the Fusogen Platform

Dec 8, 2025, 9:00 AM EST - 8 months ago

Sana Biotechnology Announces Publication in Nature Biotechnology of in vivo Gene Editing of Human Hematopoietic Stem Cells in Preclinical Models Using the Fusogen Platform

Sana Biotechnology Transcript: Evercore ISI 8th Annual HealthCONx Conference

Dec 3, 2025, 2:35 PM EST - 8 months ago

Sana Biotechnology Transcript: Evercore ISI 8th Annual HealthCONx Conference

Sana Biotechnology Transcript: Citi Annual Global Healthcare Conference 2025

Dec 2, 2025, 2:30 PM EST - 8 months ago

Sana Biotechnology Transcript: Citi Annual Global Healthcare Conference 2025

Sana Biotechnology to Present at December 2025 Investor Conferences

Nov 24, 2025, 4:05 PM EST - 8 months ago

Sana Biotechnology to Present at December 2025 Investor Conferences

Sana Biotechnology Transcript: TD Cowen Immunology and Inflammation Summit

Nov 12, 2025, 1:30 PM EST - 9 months ago

Sana Biotechnology Transcript: TD Cowen Immunology and Inflammation Summit

Sana Biotechnology reports Q3 EPS (16c), consensus (19c)

2025-11-06T23:25:54.000Z - 9 months ago

Sana Biotechnology reports Q3 EPS (16c), consensus (19c)

Sana Biotechnology Earnings release: Q3 2025

Nov 6, 2025, 7:00 AM EST - 9 months ago

Sana Biotechnology Earnings release: Q3 2025

Sana Biotechnology Quarterly report: Q3 2025

Nov 6, 2025, 7:00 AM EST - 9 months ago

Sana Biotechnology Quarterly report: Q3 2025

Sana Biotechnology Slides: Investor Presentation

Nov 5, 2025, 6:00 PM EST - 9 months ago

Sana Biotechnology Slides: Investor Presentation

Sana Biotechnology price target raised to $8 from $5 at Citizens JMP

2025-10-30T10:25:41.000Z - 9 months ago

Sana Biotechnology price target raised to $8 from $5 at Citizens JMP

Sana Biotechnology strength attributed to EMJ Capital long call

2025-10-15T17:45:20.000Z - 10 months ago

Sana Biotechnology strength attributed to EMJ Capital long call

Wedbush bullish on Sana Biotechnology, initiates with an Outperform

2025-09-24T11:45:09.000Z - 11 months ago

Wedbush bullish on Sana Biotechnology, initiates with an Outperform

Sana Biotechnology initiated with an Outperform at Wedbush

2025-09-24T10:50:09.000Z - 11 months ago

Sana Biotechnology initiated with an Outperform at Wedbush

Sana Biotechnology Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Sep 9, 2025, 9:30 AM EDT - 11 months ago

Sana Biotechnology Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Sana Biotechnology Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 8, 2025, 11:30 AM EDT - 11 months ago

Sana Biotechnology Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Sana Biotechnology Transcript: Wells Fargo 20th Annual Healthcare Conference 2025

Sep 4, 2025, 8:00 AM EDT - 11 months ago

Sana Biotechnology Transcript: Wells Fargo 20th Annual Healthcare Conference 2025

Sana Biotechnology Transcript: Citi's Biopharma Back to School Conference

Sep 2, 2025, 3:15 PM EDT - 11 months ago

Sana Biotechnology Transcript: Citi's Biopharma Back to School Conference

IQVIA and Flagship Pioneering Announce Strategic Collaboration to Accelerate the Development of Breakthrough Life Sciences Companies

Aug 28, 2025, 8:00 AM EDT - 11 months ago

IQVIA and Flagship Pioneering Announce Strategic Collaboration to Accelerate the Development of Breakthrough Life Sciences Companies

FHTX IQV MRNA

Sana Biotechnology to Present at September 2025 Investor Conferences

Aug 26, 2025, 4:05 PM EDT - 1 year ago

Sana Biotechnology to Present at September 2025 Investor Conferences

Sana Biotechnology Announces Closing of Full Exercise of Underwriters' Option to Purchase Additional Shares

Aug 20, 2025, 4:05 PM EDT - 1 year ago

Sana Biotechnology Announces Closing of Full Exercise of Underwriters' Option to Purchase Additional Shares

Sana Biotechnology reports Q2 EPS (16c), consensus (21c)

2025-08-11T20:55:26.000Z - 1 year ago

Sana Biotechnology reports Q2 EPS (16c), consensus (21c)

Sana Biotechnology Quarterly report: Q2 2025

Aug 11, 2025, 12:30 PM EDT - 1 year ago

Sana Biotechnology Quarterly report: Q2 2025

Sana Biotechnology Earnings release: Q2 2025

Aug 11, 2025, 12:30 PM EDT - 1 year ago

Sana Biotechnology Earnings release: Q2 2025

Sana Biotechnology Announces Pricing of Public Offering

Aug 6, 2025, 11:24 PM EDT - 1 year ago

Sana Biotechnology Announces Pricing of Public Offering

Sana Biotechnology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Aug 6, 2025, 4:38 PM EDT - 1 year ago

Sana Biotechnology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Seres Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Updates

Aug 6, 2025, 7:00 AM EDT - 1 year ago

Seres Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Updates

MCRB

Sana Biotechnology Announces Publication in New England Journal of Medicine of Groundbreaking Clinical Data from Transplantation Without Immunosuppression of Hypoimmune-Modified, Insulin-Producing Islet Cells in Patient with Type 1 Diabetes

Aug 4, 2025, 11:35 AM EDT - 1 year ago

Sana Biotechnology Announces Publication in New England Journal of Medicine of Groundbreaking Clinical Data from Transplantation Without Immunosuppression of Hypoimmune-Modified, Insulin-Producing Islet Cells in Patient with Type 1 Diabetes

Sana Biotechnology Announces Positive Six-Month Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression

Jun 23, 2025, 10:05 AM EDT - 1 year ago

Sana Biotechnology Announces Positive Six-Month Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression

Sana Biotechnology Transcript: Goldman Sachs 46th Annual Global Healthcare Conference

Jun 10, 2025, 8:40 AM EDT - 1 year ago

Sana Biotechnology Transcript: Goldman Sachs 46th Annual Global Healthcare Conference

Sana Biotechnology Announces Invited Oral Presentation at the 85th Annual American Diabetes Association Scientific Sessions

Jun 9, 2025, 4:05 PM EDT - 1 year ago

Sana Biotechnology Announces Invited Oral Presentation at the 85th Annual American Diabetes Association Scientific Sessions

Sana Biotechnology Transcript: Jefferies Global Healthcare Conference 2025

Jun 4, 2025, 2:35 PM EDT - 1 year ago

Sana Biotechnology Transcript: Jefferies Global Healthcare Conference 2025

Sana Biotechnology Slides: Corporate Presentation

Jun 3, 2025, 7:00 AM EDT - 1 year ago

Sana Biotechnology Slides: Corporate Presentation

Sana Biotechnology to Present at June 2025 Investor Conferences

May 28, 2025, 4:05 PM EDT - 1 year ago

Sana Biotechnology to Present at June 2025 Investor Conferences

Sana Biotechnology Transcript: BofA Securities 2025 Healthcare Conference

May 13, 2025, 12:20 PM EDT - 1 year ago

Sana Biotechnology Transcript: BofA Securities 2025 Healthcare Conference

Sana Biotechnology to Present at the BofA Securities 2025 Healthcare Conference

May 12, 2025, 4:05 PM EDT - 1 year ago

Sana Biotechnology to Present at the BofA Securities 2025 Healthcare Conference

cryptobot1234
cryptobot1234 Jul. 29 at 4:10 PM
$SANA what is going on??
0 · Reply
LoveRetailFroth
LoveRetailFroth Jul. 29 at 12:33 PM
$AMLX Good Morning ☕️ $RXRX $SANA $TEM
0 · Reply
BBraggHillBoys
BBraggHillBoys Jul. 28 at 7:14 PM
$SANA hold that $3.36 reclaim; keep that volume pumping
0 · Reply
LoveRetailFroth
LoveRetailFroth Jul. 28 at 6:50 PM
$SANA Let’s go🚀
0 · Reply
BBraggHillBoys
BBraggHillBoys Jul. 28 at 3:52 PM
$SANA a move through $3.36 with noticably accelerating volume would be a meaningful confirmation.
0 · Reply
LoveRetailFroth
LoveRetailFroth Jul. 28 at 2:23 PM
$AMLX Good Morning ☕️ My Bio 💎 s $RXRX $SANA $TEM
0 · Reply
Y007
Y007 Jul. 28 at 2:21 PM
$SANA
0 · Reply
bubbaxyz
bubbaxyz Jul. 27 at 11:25 PM
$SANA when when when🫡
0 · Reply
Harold2029
Harold2029 Jul. 27 at 6:35 PM
$SANA this will: fly, halt, fly, halt and fly some more! … mark this post!
0 · Reply
BBraggHillBoys
BBraggHillBoys Jul. 27 at 2:33 PM
$SANA in the first hour , volume increased substantially without the price giving back much of the move.
0 · Reply
LoveRetailFroth
LoveRetailFroth Jul. 27 at 2:09 PM
$SANA REVOLUTIONARY! 🚀
0 · Reply
Scrapps64
Scrapps64 Jul. 27 at 1:50 PM
$SANA Nice start today. Any news on Phase 1 clinical testing?
1 · Reply
LoveRetailFroth
LoveRetailFroth Jul. 27 at 1:42 PM
$AMLX Good Morning ☕️ My Bio 💎 s $RXRX $SANA $TEM
0 · Reply
BBraggHillBoys
BBraggHillBoys Jul. 24 at 4:17 AM
$SANA a little better volume today would have been nice but I think sellers might be getting exhausted.
0 · Reply
BBraggHillBoys
BBraggHillBoys Jul. 24 at 4:12 AM
$SANA zero in on tomorrow's volume percentage compared to average at 10:30; if 25-30%, we might be beginning/early bullish confirmation.
0 · Reply
Harold2029
Harold2029 Jul. 23 at 4:56 PM
$SANA … someone mentioned 100x … so, im going to back up the trucks and: Load UP! 🦧🦧🦧🦧💵💵💵💵
0 · Reply
BriOnH
BriOnH Jul. 22 at 5:47 PM
$SANA $ELDN https://www.lee.senate.gov/2026/7/lee-asks-hhs-to-cut-red-tape-for-life-saving-diabetes-treatment
2 · Reply
LoveRetailFroth
LoveRetailFroth Jul. 22 at 1:18 PM
$AMLX Good Morning ☕️ my Bio 💎 s. $RXRX $SANA $TEM
0 · Reply
Harold2029
Harold2029 Jul. 21 at 8:00 PM
$AMC $SANA THIS too … 100x what that is..
0 · Reply
Harold2029
Harold2029 Jul. 21 at 7:59 PM
$AMC $SANA
1 · Reply
LoveRetailFroth
LoveRetailFroth Jul. 21 at 6:15 PM
$SANA EOY $15 . Other EOY 🎯 s $RXRX - $10 $VIVO - $25 $ARBE - $8-$10 $AMLX $80 🍺
1 · Reply
JerryMalone32
JerryMalone32 Jul. 21 at 5:52 PM
$SANA up to 305,714 shares now. Average cost $4.27. In 1 year we will have a handle on whether this is a bust or whether it will have opportunity in fusogen platform and/or diabetes.
3 · Reply